DKBmed Launches New Webcast: Managing MS in Era of COVID-19

MANHATTAN, N.Y. - Feb. 1, 2022 - PRLog -- DKBmed, LLC has developed an intelligent webcast entitled Managing MS in the Era of COVID-19 through the ArcheMedX Intelligent Learning Platform (ILP). Learners participating in this program can better understand how to treat patients with multiple sclerosis (MS) during the ongoing COVID-19 pandemic.

The program can be found at covid19.dkbmed.com/multispecialty/managing-ms

As a condition with no cure, MS is managed through the use of immunomodulatory, disease-modifying therapies (DMTs). Although these medications are effective for patients with relapsing-remitting MS, the treatments elevate the risk for opportunistic infections. Results from studies suggest that many people diagnosed with MS, particularly those with comorbid conditions, have a heighted chance of developing severe cases of COVID-19. Additionally, some evidence indicates that certain classes of treatment are associated with COVID-19 severity. Because the likelihood of complications from COVID-19 is heightened in this patient population, clinicians need to take steps to mitigate risk and promote patient safety.

"COVID-19 has dramatically altered the treatment of patients with chronic conditions, and those with MS are no exception" notes Joseph Sabatino, Jr., MD, PhD, Assistant Adjunct Professor, Department of Neurology at University of California San Francisco. "As our understanding of how to combat COVID-19 evolves, so too must our strategies for caring for patients with MS. We need to be knowledgeable about strategies that maintain patient safety without sacrificing treatment efficacy."

The webinar allows learners to engage with the latest data on treatments, results from studies on the effects of COVID-19 on patients with MS, as well as recommendations published by the National MS Society. Each participant in the program will also have access to a personalized learner dashboard that promotes active study and deeper dives into specific topics of interest.

Managing MS in the Era of COVID-19 is a component of DKBmed's successful COVID-19: Keeping Up with a Moving Target program. Since its inception in March 2020, this initiative has reached over 125,000 clinicians worldwide and features more than 100 programs. The ongoing series of webinars and podcasts are freely accessible at any time on DKBmed's Hub website covid19.dkbmed.com.

About DKBmed
​DKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.

DKBmed's programs are accessible through the company's website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.